Table 2.

Inhibition Profile of α- and β-Tryptases

Protease InhibitorPercent Control
β-Tryptaseα-Tryptaseα-Tryptase (Intracellular)
(Secreted)(Secreted)
—  100 100 100 
EDTA (2 mmol/L) 95 ± 0.5 92 ± 2.5 91 ± 1.6 
Soybean trypsin inhibitor (10 μg/mL) 82 ± 0.2 85 ± 1.5 78 ± 2.8 
Aprotinin (10 μg/mL) 30 ± 0.6 35 ± 2.5 33 ± 1.8 
Benzamidine (2 mmol/L) 3.2 ± 0.5 4.5 ± 1.0 3.5 ± 1.2 
Leupeptin (0.2 mmol/L) 1.5 ± 0.3 1.0 ± 0.4 1.5 ± 0.5 
Protease InhibitorPercent Control
β-Tryptaseα-Tryptaseα-Tryptase (Intracellular)
(Secreted)(Secreted)
—  100 100 100 
EDTA (2 mmol/L) 95 ± 0.5 92 ± 2.5 91 ± 1.6 
Soybean trypsin inhibitor (10 μg/mL) 82 ± 0.2 85 ± 1.5 78 ± 2.8 
Aprotinin (10 μg/mL) 30 ± 0.6 35 ± 2.5 33 ± 1.8 
Benzamidine (2 mmol/L) 3.2 ± 0.5 4.5 ± 1.0 3.5 ± 1.2 
Leupeptin (0.2 mmol/L) 1.5 ± 0.3 1.0 ± 0.4 1.5 ± 0.5 

A total of 50 μL of the active recombinant tryptases were incubated with various known protease inhibitors for 15 minutes at 37°C. After incubation, proteolytic activity of the mixtures was compared to tryptase alone using TGPA and p-Nitroanilide generation determined at 405 nm. Activities are expressed as a percentage of maximum.

or Create an Account

Close Modal
Close Modal